Skip to main content

Table 2 Distribution of founder mutations of the BRCA1 gene in ovarian cancer patient

From: Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients

Germline mutation

All ovarian cancer (n = 125)

5382insC [exon 20]

12/125 (9.6 %)

300 T > G [exon 5]

3/125 (2.4 %)

4153delA [exon 11.17]

2/125 (1.6 %)

All mutations

17/125 (13.6 %)